Thanks to the non-invasive preimplantation genetic diagnosis it is possible to know the chromosomal endowment of the embryos without having to manipulate the embryos, thus reducing the risk of damaging them. In addition, this genetic study increases the pregnancy rate, since genetically healthy embryos will be transferred first and, therefore, with a higher probability of implantation.
Another advantage of the Embrace test is that it reduces the risk of miscarriage and implantation failure. As a consequence, the number of attempts to achieve gestation is also reduced.
Read the full article on: The Embrace test: non-invasive preimplantation genetic testing ( 50).
By Marta Barranquero Gómez B.Sc., M.Sc. (embryologist), Muriel Cuadros (senior clinical embrylogist) and Michelle Lorraine Embleton B.Sc. Ph.D. (biochemist).
Last Update: 10/26/2022